Average Co-Inventor Count = 8.15
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Alectos Therapeutics Inc. (16 from 18 patents)
2. Merck Sharp + Dohme Corp. (15 from 2,405 patents)
3. Anormed, Inc. (10 from 40 patents)
4. Genzyme Corporation (8 from 787 patents)
5. Zalicus Pharmaceuticals, Ltd. (3 from 8 patents)
6. Other (2 from 832,680 patents)
7. Simon Fraser University (1 from 155 patents)
40 patents:
1. 10913733 - Substituted piperidines thiazolyl acetamides as glycosidase inhibitors and uses thereof
2. 10322111 - Chemokine receptor binding heterocyclic compounds with enhanced efficacy
3. 10081601 - Glucocerebrosidase modulators and uses thereof
4. 9815861 - Selective glycosidase inhibitors and uses thereof
5. 9809537 - Glycosidase inhibitors and uses thereof
6. 9796680 - Glucocerebrosidase modulators and uses thereof
7. 9718854 - Selective glycosidase inhibitors and uses thereof
8. 9701693 - Selective glycosidase inhibitors and uses thereof
9. 9695197 - Glycosidase inhibitors and uses thereof
10. 9670195 - Glycosidase inhibitors and uses thereof
11. 9611275 - Permeable glycosidase inhibitors and uses thereof
12. 9522883 - Glycosidase inhibitors and uses thereof
13. 9409924 - Selective glycosidase inhibitors and uses thereof
14. 9243020 - Selective glycosidase inhibitors and uses thereof
15. 9199949 - Selective glycosidase inhibitors and uses thereof